Lineage Cell Correlations
| LCTX Stock | USD 0.50 0.10 16.67% |
The current 90-days correlation between Lineage Cell Therapeutics and MAIA Biotechnology is 0.15 (i.e., Average diversification). The correlation of Lineage Cell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Lineage Cell Correlation With Market
Modest diversification
The correlation between Lineage Cell Therapeutics and DJI is 0.27 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lineage Cell Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Lineage |
Moving against Lineage Stock
| 0.42 | RNXT | RenovoRx | PairCorr |
| 0.41 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.4 | KB | KB Financial Group | PairCorr |
| 0.39 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
| 0.38 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.35 | HPQ | HP Inc | PairCorr |
| 0.35 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.35 | T | ATT Inc Aggressive Push | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Lineage Stock performing well and Lineage Cell Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lineage Cell's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| MAIA | 3.88 | (0.53) | 0.00 | (0.57) | 0.00 | 8.37 | 28.10 | |||
| ARMP | 3.29 | 0.06 | 0.00 | 0.22 | 3.71 | 7.14 | 33.83 | |||
| FREQ | 4.38 | 0.81 | 0.11 | (0.81) | 3.90 | 5.71 | 90.18 | |||
| PRTG | 10.49 | 2.27 | 0.22 | 1.23 | 9.06 | 15.56 | 154.25 | |||
| AGE | 4.46 | 0.45 | 0.07 | 0.75 | 4.99 | 8.20 | 47.55 | |||
| CVKD | 6.06 | 1.19 | 0.20 | 0.59 | 6.02 | 17.85 | 47.47 | |||
| ICCC | 1.75 | 0.14 | (0.02) | (0.09) | 2.33 | 3.40 | 21.64 | |||
| ONTTF | 3.69 | 0.21 | 0.04 | 0.39 | 4.03 | 11.11 | 21.94 | |||
| REPL | 3.10 | 0.47 | 0.16 | 0.36 | 2.86 | 7.38 | 15.63 | |||
| NVCT | 4.31 | (0.46) | 0.00 | (0.04) | 0.00 | 10.84 | 75.91 |
Lineage Cell Corporate Management
| Charlotte Hubbert | Vice Development | Profile | |
| Jill Howe | CFO Officer | Profile | |
| DVM Dvm | VP Affairs | Profile | |
| Alexandra Hernandez | Senior Controller | Profile | |
| JD III | General Secretary | Profile | |
| Ioana Hone | Director Relations | Profile |